Medocriptine

Bromocriptine, the active ingredient in Medocriptine, is a ergot dopamine agonist presented as a tablet for oral use. It is used to manage Parkinson's disease, hyperprolactinemia and type 2 diabetes mellitus in adult patients. GNH USA supplies Medocriptine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medocriptine acts on dopaminergic pathways and is indicated for several endocrine and neurological conditions. - Parkinson's disease: improves motor control by stimulating central dopamine receptors. - Hyperprolactinemia: lowers excess prolactin levels, helping restore normal menstrual cycles and fertility. - Type 2 diabetes mellitus: enhances peripheral insulin sensitivity and contributes to better glycaemic control.

Bromocriptine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Dizziness - Fatigue - Constipation - Hypotension

Serious or Rare Side Effects: - Valvular heart disease - Pulmonary fibrosis - Severe hypotension with syncope - Psychotic episodes - Seizures - Hepatic dysfunction

When prescribing Medocriptine, clinicians should consider several safety measures. - Blood pressure monitoring: watch for orthostatic hypotension, especially at treatment initiation. - Cardiac assessment: evaluate for pre‑existing valvular disease before long‑term use. - Psychiatric evaluation: monitor for emergence of hallucinations or psychosis. - Renal function: adjust dosing in patients with severe impairment. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Bromocriptine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) – may increase bromocriptine levels. - Other ergot derivatives (e.g., ergotamine) – additive risk of vasospasm and cardiac valvulopathy. - Strong antihypertensives – can cause excessive hypotension.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs) – may enhance serotonergic effects. - Antipsychotics (haloperidol, risperidone) – may reduce dopaminergic efficacy. - Antidiabetic agents – monitor glucose as bromocriptine can improve glycaemic control. - NSAIDs – may increase risk of gastrointestinal irritation.